NEW YORK (GenomeWeb) – Quest Diagnostics on Friday said that it expects revenues to grow 3 percent to 5 percent and earnings to grow in the mid- to high-single digits annually from 2017 to 2020.

The Madison, New Jersey-based firm also said it plans to raise its common stock dividend by more than 12 percent to an annual rate of $1.80 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.